Final Products
    Intermediates
    Intermediates of Larotrectinib(LOXO-101)
    Intermediates of Ivabradine
    Intermediates of Dacomitinib
    Intermediates of Efinaconazole
    Intermediates of Olodaterol
    Intermediates of Ticagrelor
    Intermediates of Entrectinib
    Intermediates of Acotiamide
    Intermediates of Dofetilide
    Piperazine derivative
    Piperidine derivative
    Pyrrolidine derivative
    Pyridine derivative
    Other Intermediates
    Intermediates of Mirabegron
    Intermediates of Tiotropium Bromide
    Intermediates of Vilanterol
    Intermediates of Umeclidinium bromide
    Intermediates of Glycopyrrolate Bromide
    Intermediates of Donepezil HCI
     
      News Center

     

    Our company has been appraised as Fuyang's major specialized special new small and medium-sized enterprise


    According to "Fuyang special new small and medium-sized enterprise identification standards and procedures" (Fu private run [2014] No. 3) requirements,
    After the declaration, the County Commission Committee recommended by the organization, expert approval and other procedures, our company was officially identified as Fuyang specialized new small and medium-sized enterprises.

     

     

    Copyright(C)2017 , Jinan Dexinjia Bio&Tech Co.,Ltd. All Rights Reserved.  Supported by  ChemNet  ChinaChemNet Toocle Copyright Notice
     
    點擊這里給我發消息
    聯系我們
    點擊這里給我發消息
    在線交流
    點擊這里給我發消息
    聯系我們
     
     
     
     
    免费国产乱理伦片在线观看